J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M700470-JLR200 on May 28, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M700470-JLR200v1
49/9/1904    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Calpe-Berdiel, L.
Right arrow Articles by Escolà-Gil, J. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calpe-Berdiel, L.
Right arrow Articles by Escolà-Gil, J. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 49, 1904-1911, September 2008
Copyright © 2008 by American Society for Biochemistry and Molecular Biology

Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8

Laura Calpe-Berdiel1,*, Noemí Rotllan1,*, Catherine Fiévet{dagger},§,**, Rosa Roig{dagger}{dagger}, Francisco Blanco-Vaca2,{dagger}{dagger},§§,*** and Joan Carles Escolà-Gil2,*,***

* Institut de Recerca, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain
{dagger}{dagger} Servei de Bioquímica, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain
{dagger} Institut Pasteur de Lille, Lille, F-59019 France
§ Insitut National de la Santé et de la Recherche Médicale, U545, Lille, F-59019 France
** Faculté des Sciences Pharmaceutiques et Biologiques et Faculté de Médecine, Université de Lille 2, Lille, F-59006 France
§§ Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Barcelona, 08025 Spain
*** CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Barcelona, 08036 Spain

Published, JLR Papers in Press, May 28, 2008.

This work was funded by Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Red FIS RD06/0015, and Grant FIS PI06/0551. N.R. is a predoctoral fellow of Fondo de Investigaciones Sanitarias (05/00221). J.C.E-G. is a Ramón y Cajal researcher, funded by the Ministerio de Educación y Ciencia.

1 L. Calpe-Berdiel and N. Rotllan contributed equally to this work.

2 To whom correspondence should be addressed. e-mail: fblancova{at}santpau.es (F.B-V.); jescola{at}santpau.es (J.C.E-G.)

Liver X receptor (LXR) agonists increase both total fecal sterol excretion and macrophage-specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of ABCG5/G8 deficiency as well as those of LXR agonist-induction of RCT from macrophages to feces in vivo. A [3H]cholesterol-labeled macrophage cell line was injected intraperitoneally into ABCG5/G8-deficient (G5/G8–/–), heterozygous (G5G8+/–), and wild-type G5/G8+/+ mice. G5/G8–/–mice presented increased radiolabeled HDL-bound [3H]cholesterol 24 h after the label injection. However, the magnitude of macrophage-derived [3H]cholesterol in liver and feces did not differ between groups. A separate experiment was conducted in G5G8+/+ and G5G8–/– mice treated with or without the LXR agonist T0901317. Treatment with T0901317 increased liver ABCG5/G8 expression, which was associated with a 2-fold increase in macrophage-derived [3H]cholesterol in feces of G5/G8+/+ mice. However, T0901317 treatment had no effect on fecal [3H]cholesterol excretion in G5G8–/– mice. Additionally, LXR activation stimulated the fecal excretion of labeled cholesterol after an intravenous injection of HDL-[3H]cholesteryl oleate in G5/G8+/+ mice, but failed to enhance fecal [3H]cholesterol in G5/G8–/– mice. Our data provide direct in vivo evidence of the crucial role of ABCG5 and ABCG8 in LXR-mediated induction of macrophage-specific RCT.

Supplementary key words HDL • LXR agonist • mice


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.